Boehringer Ingelheim touts 10-year plan as it eyes overtaking Bayer as Germany’s largest pharma
Boehringer Ingelheim put the spotlight on a pipeline ripe with milestones over the next decade during its full-year 2023 earnings call with the press. Driven in part by the blockbuster success of its diabetes and heart drug Jardiance, Boehringer may have surpassed Bayer to become the biggest German drugmaker, according